Open | 0.47 |
Previous Close | 0.4899 |
Day Range | 0.45 - 0.49 |
52-Week Range | 0.43 - 3.10 |
All-Time High | 784.00 |
Avg. Volume (50-day) | 511,511.7 |
EPS (TTM) | -1.6162 |
Next Earnings Date | - |
Last Earnings Date | - |
Forward Annual Dividend (Yield) | - |
Trailing Annual Dividend (Yield) | - |
Options | No |
P/E Ratio | -0.3000 |
PEG Ratio | - |
Price to Book | 1.49 |
Price to Cash Flow | - |
Price to Free Cash Flow | - |
Total Sales (TTM) | - |
Revenue per Share (TTM) | - |
Shares Outstanding | 14.429 M |
Share Float (%) | 11.61 M |
% Held by Institutions | 14.20 |
Dividends Per Share (TTM) | - |
Ex-Dividend Date | - |
+/- EMA(20) | 0.6 (-18.17%) |
+/- SMA(50) | 0.75 (-34.53%) |
+/- SMA(200) | 1.24 (-60.40%) |
5-Day Perf. | -1.05% |
1-Month Perf. | -40.48% |
3-Month Perf. | -49.38% |
6-Month Perf. | -55.57% |
YTD Perf. | -41.69% |
1-Year Perf. | -80.04% |
RSI(14) | 28.06 |
ATR(14) | 0.09 |
ADX(14) | 21.9 |
Beta (5Y) | 1.21 |
As a StockCharts Member, you can review earnings results and analyze revenue and earnings growth over time. Bring a balance of technicals and fundamentals to your approach when you join today!
Indaptus Therapeutics, Inc. is a pre-clinical biotechnology company. It engages in the development of a novel and patented systemically-administered anti-cancer and anti-viral immunotherapy. The firm created patented treatment methods and associated patented compositions for attenuation and killing of non-pathogenic, Gram-negative bacteria. The company was founded by Michael James Newman on February 24, 2021 and is headquartered in New York, NY.
INDP has triggered the following predefined scans:
P&F Double Bottom Breakdown |
P&F Descending Triple Bottom Breakdown |
As a StockCharts Member, you can create your own unique alerts with the technical criteria that matters most to you. Stay ahead of important moves and never miss a thing in the markets.
As a StockCharts Member, you can save the charts you're watching to your own account with ChartLists. Accessible from any device, you can organize, review and analyze your charts on-the-go, anytime, anywhere.